Women fare better than men, but need more blood after kidney cancer surgery

Key points
- Women do better than men after surgical removal of part or all of a cancerous kidney, with fewer post-operative complications, including dying in the hospital, although they are more likely to receive blood transfusions related to their surgery.
- But Henry Ford Hospital researchers who documented these gender differences can't say why they exist.
- The results of the new study, based on population samples from throughout the U.S., will be presented this week at the American Urological Association's Annual Meeting in Atlanta.
- "This is a controversial area," says Quoc-Dien Trinh, M.D., a Fellow at Henry Ford Hospital's Vattikuti Urology Institute and lead author of the study.
Women do better than men after surgical removal of part or all of a cancerous kidney, with fewer post-operative complications, including dying in the hospital, although they are more likely to receive blood transfusions related to their surgery.
But Henry Ford Hospital researchers who documented these gender differences can't say why they exist.
The results of the new study, based on population samples from throughout the U.S., will be presented this week at the American Urological Association's Annual Meeting in Atlanta.
"This is a controversial area," says Quoc-Dien Trinh, M.D., a Fellow at Henry Ford Hospital's Vattikuti Urology Institute and lead author of the study.
"While the effects of gender on the outcome of many types of surgery, including removal of the bladder, have been demonstrated and widely debated, the association between gender and surgical outcomes of nephrectomy (kidney removal) is not well understood."
Physical differences between genders can explain different outcomes in some types of surgery, and have been shown and discussed in several earlier studies, Dr. Trinh says. "But this is hard to explain for nephrectomies. There is no clear-cut anatomical difference between men and women that would explain why it's easier or harder in one sex than the other."
Surgical removal of part or all of a diseased kidney, whether using traditional "open" techniques or less-intrusive laparoscopic procedures, is the standard of care for kidney cancer and the only curative treatment.
Using nephrectomy data from 1998 through 2007, the most recent available from the Health Care Utilization Project's Nationwide Inpatient Sample (NIS), "we tested the rates of blood transfusions, extended length of stay (beyond the median of five days), in-hospital mortality, as well as complications during and after surgery, separated by gender," Dr. Trinh says.
Of the total 48,172 cases that were identified and examined, 18,966 (39.4 percent) were female. The mean age for the women was 62.7 years; for the men, 61.8 years.
While no significant gender-related differences were found in complications during surgery and length of hospital stay after surgery, the Henry Ford Hospital researchers found that women:
Were less likely than men (14.6 percent vs. 17.1 percent) to have complications after nephrectomy. These included digestive problems, hemorrhage, cardiac complications and infections.
Were less likely to die while in the hospital (0.6 percent vs. 0.8).
Were more likely to have blood transfusions than men (11.5 percent vs.9.2 percent).
The differences were most pronounced after partial removal of a cancerous kidney using open surgical techniques.
Because researchers didn't have specific data on the kidney tumors in each individual case, exactly why these differences were found couldn't be determined, Dr. Trinh says, adding, "It is entirely possible that women have smaller tumors, so there are fewer complications."
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsStudy may help reassure women taking tamoxifen for breast cancer
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer. The multi-center study was presented during the 2016 annual…
7 June 2016
NewsToward a better understanding of the mechanisms blocking cancer cell growth
DNA damage can lead to gene inactivation or deregulation and cause various diseases such as cancer; however, many DNA repair mechanisms allow cells to survive against such damage. A study lead by Antoine Simoneau of the…
29 January 2016
GuideNew method for better treatment of breast cancer
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The…







